Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
300 participants
INTERVENTIONAL
2008-03-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
NCT00792727
A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis
NCT06047483
Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee
NCT00108810
A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee
NCT04683627
Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee
NCT00488267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A, 2, II, HKT-500 Topical Patch
A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee
HKT-500 Topical Patch
Treatment with Ketoprofen Topical Patch
Placebo Patch
Treatment with placebo patch
Placebo Patch
Treatment with placebo patch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HKT-500 Topical Patch
Treatment with Ketoprofen Topical Patch
Placebo Patch
Treatment with placebo patch
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with osteoarthritis of the knee
Exclusion Criteria
* who has a positive urine pregnancy test,
* is lactating, or who is not surgically sterile
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hisamitsu Pharmaceutical Co., Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenichi Furuta
Role: STUDY_DIRECTOR
Hisamitsu
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hisamitsu Investigator Site
Birmingham, Alabama, United States
Hisamitsu Investigator Site
Phoenix, Arizona, United States
Hisamitsu Investigator Site
Little Rock, Arkansas, United States
Hisamitsu Investigator Site
Little Rock, Arkansas, United States
Hisamitsu Investigator Site
Burbank, California, United States
Hisamitsu Investigator Site
Escondido, California, United States
Hisamitsu Investigator Site
Northridge, California, United States
Hisamitsu Investigator Site
Colorado Springs, Colorado, United States
Hisamitsu Investigator Site
DeLand, Florida, United States
Hisamitsu Investigator Site
Hallandale, Florida, United States
Hisamitsu Investigator Site
Ocala, Florida, United States
Hisamitsu Investigator Site
Ormond Beach, Florida, United States
Hisamitsu Investigator Site
Austell, Georgia, United States
Hisamitsu Investigator Site
Savannah, Georgia, United States
Hisamitsu Investigator Site
Stockbridge, Georgia, United States
Hisamitsu Investigator Site
Chicago, Illinois, United States
Hisamitsu Investigator Site
Madisonville, Kentucky, United States
Hisamitsu Investigator Site
Baton Rouge, Louisiana, United States
Hisamitsu Investigator Site
Lake Charles, Louisiana, United States
Hisamitsu Investigator Site
Flint, Michigan, United States
Hisamitsu Investigator Site
Omaha, Nebraska, United States
Hisamitsu Investigator Site
Berlin, New Jersey, United States
Hisamitsu Investigator Site
Raleigh, North Carolina, United States
Hisamitsu Investigator Site
Cincinnati, Ohio, United States
Hisamitsu Investigator Site
Zanesville, Ohio, United States
Hisamitsu Investigator Site
Oklahoma City, Oklahoma, United States
Hisamitsu Investigator Site
Duncansville, Pennsylvania, United States
Hisamitsu Investigator Site
Houston, Texas, United States
Hisamitsu Investigator Site
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKT-500-US12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.